NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1030230180

Registered date:25/06/2023

Validation of the reduced morningness-eveningness questionnaire (rMEQ: reduced morningness-eveningness questionnaire) in Japanese

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedCircadian rhythm disorders
Date of first enrollment25/06/2023
Target sample size2243
Countries of recruitment
Study typeInterventional
Intervention(s)In Study 2, the subjects spend 6 hours in a dark (less than 1 lx illumination) laboratory and saliva is collected once an hour.

Outcome(s)

Primary OutcomeAssociation between chronotypes determined by MEQ and rMEQ, respectively Association between DLMO and sleep rhythm phase and chronotypes determined by rMEQ
Secondary OutcomeQuestionnaires with significant contribution to chronotype determination Association of chronotype with sleep irregularities

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum<= 79age old
GenderBoth
Include criteriaStudy 1: 1) Persons who are between 20 and 79 years old at the time of response. 2) Who are able to respond to the questionnaire via the Internet. Study 2 1) Males and females between 20 and 60 years of age at the time of consent
Exclude criteriaStudy 1:. 1) Persons with pre-existing medical conditions (cardiovascular, liver, endocrine system, brain/neurological, psychiatric, etc.), taking therapeutic drugs, or having a history of such conditions that may affect the study results 2) Persons who are dependent on alcohol or who are found to be in the habit of excessive alcohol consumption 3) Those who have a habit of taking drugs or supplements that affect sleep. 4) Pregnant, lactating, or planning to become pregnant during the study period 5) Who are using an implantable medical device such as a pacemaker 6) Any other person deemed inappropriate by the principal investigator. Study 2: The following are not included in the study 1) Persons with pre-existing medical conditions (cardiovascular, liver, endocrine, brain/neurological, psychiatric, etc.), taking therapeutic drugs, or having a history of such conditions that may affect the results of the study 2) Those who have engaged in time-lagged travel or shift work at least 6 months prior to the experiment. 3) Persons who have been found to be dependent on alcohol or to have excessive drinking habits 4) Persons with excessive smoking habits 5) Those who have a habit of taking drugs or supplements that affect sleep 6) Those with abnormal color vision 7) Those who have a phobia of dark places 8) Other subjects deemed inappropriate by the principal investigator

Related Information

Contact

Public contact
Name Eto Taisuke
Address 4-1-1 Ogawa-Higashi, Kodaira, Tokyo Tokyo Japan 187-8551
Telephone +81-42-346-2071
E-mail eto@ncnp.go.jp
Affiliation National Center of Neurology and Psychiatry
Scientific contact
Name Shingo Kitamura
Address 4-1-1 Ogawa-Higashi, Kodaira, Tokyo Tokyo Japan 187-8551
Telephone +81-42-346-2071
E-mail s-kita@ncnp.go.jp
Affiliation National Center of Neurology and Psychiatry